01—Abstract
Summary
Summary of the 10-K filed February 26, 2015. Cited figures are marked; the original filing is the authoritative source.
Aflac Incorporated's 2014 Form 10-K highlights a year of resilience amidst a weakening yen, reporting total revenues of $22.7 billiona and net earnings of $3.0 billion.
The company's operations are heavily concentrated in Japan, which accounted for 72%b of total revenues and 82% of total assets in 2014. Aflac Japan's performance was impacted by the yen's depreciation against the U.S. dollar, leading to a reported decrease in dollar-denominated revenues and net earnings compared to 2013. However, on a yen-operating basis, Aflac Japan showed stable pretax operating earnings, driven by strong performance in its core cancer and medical insurance products, with the introduction of the "New Cancer DAYS" product showing promising early results.
In the U.S., Aflac U.S. demonstrated moderate growth in premium income and pretax operating earnings, supported by product enhancements and strategic sales initiatives. The company continued its share repurchase program, returning $1.2 billionc to shareholders through repurchases and dividends in 2014.
Aflac's strong capital position and robust risk management framework are key strengths, with the company maintaining high solvency margin ratios and regulatory capital levels in both its U.S. and Japanese operations. The report also details the company's exposure to market risks, particularly currency fluctuations and interest rate sensitivity, and outlines its hedging strategies to mitigate these risks.
02—Key points
Key Highlights
- Aflac Japan remains the dominant contributor to Aflac's overall financial performance, accounting for 72% of total revenues in 2014. The weakening yen negatively impacted dollar-denominated results, though yen-based operating earnings remained stable.
- The company introduced "New Cancer DAYS" in Japan, which showed a significant 176% increase in cancer insurance sales for Q4 2014, indicating positive market reception.
- Aflac U.S. reported a modest increase in premium income and pretax operating earnings, with strategic sales initiatives and product enhancements contributing to growth.
- Shareholder returns were robust, with $1.2 billion allocated to share repurchases and dividends in 2014, demonstrating a commitment to capital allocation.
- Aflac maintains a strong financial position, evidenced by high solvency margin ratios in Japan and robust risk-based capital ratios in the U.S., indicating strong capital adequacy.
- The company proactively manages market risks, particularly currency fluctuations and interest rate impacts, through hedging strategies and a diversified investment portfolio.
- Despite challenges like low interest rates in Japan, Aflac's diversified product portfolio and strong distribution channels in both markets provide a foundation for continued stability and growth.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2014filed February 26, 2015Financial Statements
FY2014 against FY2013
| Line item | FY2014FY2013 | Change |
|---|---|---|
| Revenue | $22.73B$23.94B | −5.1% |
| SG&A Expenses | $2.26B$2.22B | +1.8% |
| Operating Income | $4.25B$4.40B | −3.3% |
| Interest Expense | $317.00M$293.00M | +8.2% |
| Net Income | $2.95B$3.16B | −6.6% |
| EPS (Basic) | $3.27$3.40 | −3.8% |
| EPS (Diluted) | $3.25$3.38 | −3.8% |
| Shares Outstanding (Basic) | 902.41M929.00M | −2.9% |
| Shares Outstanding (Diluted) | 908.00M934.82M | −2.9% |
05—Questions
Frequently Asked Questions
What is Aflac's primary source of revenue and profit?
Aflac's primary source of revenue and profit is its insurance business, with a significant concentration in Japan. Aflac Japan accounted for 72% of the company's total revenues in 2014, highlighting its critical role in the company's financial performance.
How did the weakening yen impact Aflac's financial results?
The weakening yen against the U.S. dollar negatively impacted Aflac's reported financial results in dollar terms. This led to a decrease in total revenues and net earnings when translated into U.S. dollars, although the company's underlying yen-based operating performance remained stable.
What is Aflac's strategy for managing market risks?
Aflac employs a comprehensive risk management framework that includes hedging strategies to mitigate currency fluctuations and interest rate risks. The company also maintains a diversified investment portfolio to manage credit risk and market volatility.
How is Aflac returning capital to shareholders?
In 2014, Aflac returned capital to shareholders through share repurchases totaling $1.2 billion and dividend payments. The company plans to continue its share repurchase program and dividend payments, subject to financial performance and strategic considerations.
What are Aflac's key product offerings in its primary markets?
In Japan, Aflac focuses on supplemental cancer and medical insurance, along with life insurance and annuities. In the U.S., the company offers a range of voluntary supplemental insurance products, including accident, critical illness, hospital indemnity, dental, vision, and life insurance.
06—Continue